Influence of water soluble polymers on hydroxypropyl-β-cyclodextrin complexation of rofecoxib

Pharmazie

Volumn 62, Issue 4, 2007, Pages 284-286

  Singh, I ^a   Aboul Enein, H Y ^b  

^a Akal College of Pharmacy and Technical Education   (India)

^b UNIVERSITY OF SHARJAH   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CARBOXYMETHYLCELLULOSE; MACROGOL; POVIDONE IODINE; ROFECOXIB;

ARTICLE; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE; X RAY DIFFRACTION;

BETA-CYCLODEXTRINS; CARBOXYMETHYLCELLULOSE; CRYSTALLOGRAPHY, X-RAY; CYCLOOXYGENASE 2 INHIBITORS; DRUG COMPOUNDING; KINETICS; LACTONES; MAGNETIC RESONANCE SPECTROSCOPY; METHYLCELLULOSE; POLYMERS; POVIDONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFONES; WATER;

EID: 34247129092     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.4.6154     Document Type: Article

References (9)

1. Abdou HM (1989) Theory of Dissolution: In Dissolution Bioavailability and Bioequivalence, Pennsylvania, Mack Publishing Company, Ch-2, p 11.
2. Barden J, Edwards J, Moore RA, McQuay HJ (2005) Single dose oral rofecoxib for portoperative pain. Cochrane Database of Systematic Reviews (1): CD 004604.
3. Beckers O, Utjtendal EV, Beijmen JH, Bull A, Underberg WJM (1991) Cyclodextrin in the pharmaceutical field. Drug Dev Ind Pharm 17, 1503-1509.
4. Harel Z (2004) Cyclooxygenase-2 specific inhibitors in the treatment of dysmenorrhea. J Pediar Adolesc Gynecol 17: 75-79.
5. Higuchi T, Connors KA (1965) in Reilly CN (ed) Advances in Analytical Chemistry and Instrumentation, Reilly, CN Ed, Wiley-Interscience, New York, Vol 4, pp 117-212.
6. Loftsson T, Frioriksdottir H, Sigurdardottir AM, Ueda H (1994) The effect of water soluble polymers on drug-cyclodextrin complexation. Int J Pharm 110: 169-177.
7. Loftsson T, Gudmundsdottir TK, Frioriksdottir H (1996) The influence of water soluble polymers and pH on hydroxypropyl-β-cyclodextrin complexation of drugs. Drug Dev Ind Pharm 22: 401-405.
8. Matheson AJ, Figgitt DP (2001) Rotecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis. Drugs 61: 833-865.
9. Schmidt H, Woodcock BG, Geisslinger G (2004) Benefit-risk assessment of robecoxib in the treatment of osteoarthritis. Drug Safety 27: 185-196.